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Introduction
============

Thyrotoxic cardiomyopathy (TCM) is an uncommon presentation in hyperthyroid patients. TCM has been reported in 6% of hyperthyroidism cases, with less than 1% developing dilated cardiomyopathy (DCM) and severe left ventricular dysfunction \[[@REF1]\]. The effects of thyroid hormone at the cellular level may cause alterations of peripheral circulation by interacting with the sympathetic nervous system \[[@REF2]\].

Case presentation
=================

We present a case of a 30-year-old female who presented with a complaint of watery diarrhea for almost one week. She went to a primary care physician with a complaint of watery stools, wherein she presented with an elevated heart rate of \>200 beats per minute. The patient was transferred to an emergency room with an altered mental status, unresponsiveness, and hemodynamic instability. We initiated fluid resuscitation and gave her procainamide for arrhythmia or tachycardia with heart rate \>200 per minute. Afterward, her heart rate decreased to around 170 beats per minute. However, she was subsequently on continuous positive airway pressure (CPAP) in the setting of acute respiratory distress. Considering the worsening of respiratory distress despite being on CPAP, the patient was intubated. She also required vasopressor support, including dobutamine, norepinephrine, and vasopressin. The neurological assessment revealed diffuse hyperreflexia. The computed tomography (CT) scan was non-contributory. Chest X-ray showed pulmonary vascular congestion with right pleural effusion and cardiomegaly (Figure [1](#FIG1){ref-type="fig"}).

![Chest X-ray: Diffuse bilateral pulmonary vascular congestion (black arrows bilaterally) with impending ARDS\
ARDS, acute respiratory distress syndrome](cureus-0012-00000008213-i01){#FIG1}

Electrocardiogram on admission showed atrial flutter with right axis deviation, incomplete right bundle branch block, and ST elevation indicative of septal ischemia (Figure [2](#FIG2){ref-type="fig"}). 

![ECG: atrial flutter (Red circle) with right axis deviation, incomplete right bundle branch block, and ST elevation (red arrow) indicative of septal ischemia\
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The elevated troponins with delta trend pushed further diagnostic workup. Echocardiography (ECHO) showed an ejection fraction of 10% to 15%, global hypokinesis, and dilated left ventricle with small pericardial effusion (Figure [3](#FIG3){ref-type="fig"}).

![Echocardiography\
\[A, B\] Global hypokinesis, dilated left ventricle and pericardial effusion (white arrows)](cureus-0012-00000008213-i03){#FIG3}

The patient was brought to the cardiac catheterization lab emergently for mechanical circulatory support. Due to the elevated lactic acid levels and mixed acidosis on arterial blood gas (ABG), we started her on broad-spectrum empiric antibiotics. The serum ammonia and procalcitonin levels were within normal limits. Continuous renal replacement therapy (CRRT) initiated due to worsening acute kidney injury and hyperkalemia secondary to thyrotoxicosis induced rhabdomyolysis. The laboratory investigations are shown in Table [1](#TAB1){ref-type="table"}.

###### Laboratory Findings

  ------------------------------------- -------------------------------------- -----------------------
  Laboratory Variables                  Findings                               Normal Values
  Serum Sodium (Na)                     132 mEq/L                              135-145 mEq/L
  Serum Potassium (K)                   6.7 mEq/L                              3.5-5.0 mEq/L
  Serum Chloride                        101 mEq/L                              98-108 mEq/L
  Serum Bicarbonate (HCO3)              13 mEq/L                               21-32 mEq/L
  Anion Gap                             18 mEq/L                               5-14 mEq/L
  Serum Total Calcium (Ca)              7.2 mg/dl                              8.5-10.1 mg/dl
  Serum Magnesium (Mg)                  2.3 mg/dl                              1.8-2.4mg/dl
  Blood Glucose                         79 mg/dl                               70-100 mg/dl
  Serum Creatinine (Cr)                 2.3 mg/dl                              0.6-1.1 mg/dl
  Glomerular Filtration Rate (GFR)      25 mL/min/1.73 m2                      =/\>60 mL/min/1.73 m2
  Blood Urea Nitrogen (BUN)             53 mg/dl                               7-18 mg/dl  
  Total Creatinine Kinase (CK)          2141 U/L                               26-192 U/L
  Alanine Aminotransferase (ALT)        1944 U/L                               12-78 U/L
  Aspartate Aminotransferase (AST)      5336 U/L                               15-37 U/L
  Alkaline Phosphatase (ALP)            235 U/L                                45-117 U/L
  Total Bilirubin                       4.3 mg/dl                              0.2-1 mg/dl
  Bilirubin Direct                      3.3 mg/dl                              0.0-0.2 mg/dl  
  Albumin                               2.7 g/dl                               3.1-4.5 g/dl
  Procalcitonin                         0.06 nanogram/milliliter (ng/ml)       0.15 ng/mL or less
  Thyroid Stimulating Hormone (TSH)      \<0.005 milliunits per liter (mU/L)   0.358-3.740 (mU/L)
  Free Triiodothyronine (fT3)           \>30 ng/dl                             2.18-3.98 ng/dl
  Free Thyroxine (fT4)                  \>8.00 ng/dl                           0.76-1.46 ng/dl
  ------------------------------------- -------------------------------------- -----------------------

She suffered from multi-organ failure and sepsis with elevated levels of liver function enzymes. Thionamides were discontinued after the development of acute transaminitis. She was treated with hydrocortisone 100 mg every intravenous (IV) eight hours, potassium iodide five drops every six hours, and cholestyramine IV 4 g every eight hours.

There were multifaceted management plans under consideration at that stage ranging from extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pump (IABP), and left the ventricular assisted device (LVAD). Unfortunately, the patient coded blue and lost pulse during heart catheterization for IABP. Cardiopulmonary resuscitation (CPR) was done for 30 minutes without the return of spontaneous circulation (ROSC). The decision to stop CPR was made by her family, the primary service, and the consulting cardiology team.

Discussion
==========

Heart failure is an unusual presentation of hyperthyroidism and can only occur in 6% of cases. About 50% of such cases come under the sub-group of high output failure with preserved ventricular ejection fractions (\>50%). TCM cases are also highly associated with coexisting atrial fibrillation \[[@REF1]\]. Cardiogenic shock (CS) is a rare complication of thyroid storm (TS), and minimal data exists on its incidence and outcomes. Mohananey D et al. mentioned some of the preluding factors for thyrotoxicosis-induced CS. These include preexisting congestive heart failure, valvular disorders, atrial fibrillation, coagulopathy, alcohol or drug abuse, fluid and electrolyte disorders, liver, renal or pulmonary disorders, and weight loss as compared to those without CS \[[@REF2]\]. The decreased contractile reserve with impaired left ventricular filling might contribute to CS with encephalopathy \[[@REF3]\]. The pathophysiology of TCM is unclear and complicated in literature. It is multifactorial with both the toxicogenic effects of thyroid hormones and hyperdynamic cardiogenic stress \[[@REF4]\]. However, antithyroid treatment has shown to reverse the cardiomyopathy effects of thyrotoxicosis \[[@REF5]-[@REF6]\].

In a recent study by Smith et al., the disappearance of cardiovascular outcomes with the achievement of euthyroid state after treatment was observed in patients with long-term subclinical hyperthyroidism \[[@REF7]\]. We tried thionamides but discontinued later due to the development of acute transaminitis in the setting of sepsis. Kim S et al. reported the reversibility of TCM-associated reduced ejection fraction to almost normal after venous-arterial ECMO \[[@REF8]\]. Unfortunately, in our case, the patient expired before getting ECMO from hemodynamic collapse. The management of hyperthyroidism associated with acute heart failure is complicated. It demands invasive monitoring with circulatory support. Some patients might lead to CS despite the reversible nature of TCM with aggressive treatment \[[@REF8]-[@REF9]\]. Therefore, early recognition and successful treatment of cardiac symptoms in patients with hyperthyroidism are essential.

The limitation in our case was time; the patient went to ARDS and cardiogenic shock with encephalopathy within 24 hours. The aggressive progression of TCM leaves us with a dilemma of realizing the gravity of the problem. The life-saving and multi-modal interventions like IABP or ECMO should be initiated earlier in such cases within 24 hours of impending ARDS. Besides, owing to time constraints, brain magnetic resonance imaging (MRI) could not be performed to detect a white matter or profound structural changes missed by CT scan. 

Conclusions
===========

The mortality associated with TCM is sudden and includes a series of irreversible events. Our patient developed TCM with CS and encephalopathy despite exhausting all conventional resuscitative measures. Hyperthyroid states induce multi-organ failure including heart, hepatic, and renal failure along with lactic acidosis. Further studies should be done to evaluate the pathogenesis of TCM leading to the development of the least-invasive, safe, and definitive treatment options. 
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